Alphabet Inc.
Holdings as of 2026-06-30, filed 2026-08-07 · recorded 2026-08-08 03:50:44.412 UTC
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 38 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
29
Value reported by manager
$99.1B
Sum of our stored positions
$99.1B
should match the line above
Disclosure lag
38 d
quarter end to filing
Top 5 concentration
98.5%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
29 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP | CLASS A COM STK | $94.2B | 551,189,500 | — | 84615Q103 |
| PLANET LABS PBC | COM CL A | $1.2B | 35,248,893 | — | 72703X106 |
| AST SPACEMOBILE INC | COM CL A | $794.7M | 8,943,486 | — | 00217D100 |
| CME GROUP INC | COM | $769.4M | 3,484,020 | — | 12572Q105 |
| ARM HOLDINGS PLC | SPONSORED ADS | $695.2M | 1,960,784 | — | 042068205 |
| REVOLUTION MEDICINES INC | COM | $551.8M | 2,946,619 | — | 76155X100 |
| FRESHWORKS INC | CLASS A COM | $145M | 14,327,273 | — | 358054104 |
| PARABILIS MEDICINES INC | COM | $134.6M | 4,919,498 | — | 698955101 |
| TEMPUS AI INC | CL A | $89.9M | 1,551,102 | — | 88023B103 |
| GITLAB INC | CLASS A COM | $83.2M | 2,724,712 | — | 37637K108 |
| UIPATH INC | CL A | $76.5M | 7,034,337 | — | 90364P105 |
| ETHOS TECHNOLOGIES INC | CL A | $65.7M | 3,622,604 | — | 29765A101 |
| PRIME MEDICINE INC | COM | $61.1M | 16,562,498 | — | 74168J101 |
| FERVO ENERGY CO | CL A COM | $51.5M | 1,760,732 | — | 31556C106 |
| PAYPAY CORP | SPONSORED ADS | $44.8M | 3,125,000 | — | 70450C101 |
| MAZE THERAPEUTICS INC | COM | $41.4M | 1,388,583 | — | 578784100 |
| RELAY THERAPEUTICS INC | COM | $26.4M | 1,410,029 | — | 75943R102 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $21.5M | 2,823,126 | — | 107924102 |
| FRESHWORKS INC | CLASS A COM | $19M | 1,879,370 | — | 358054104 |
| OSCAR HEALTH INC | CL A | $13.7M | 481,988 | — | 687793109 |
| BEAM THERAPEUTICS INC | COM | $11M | 321,604 | — | 07373V105 |
| VERA THERAPEUTICS INC | CL A | $10.4M | 241,264 | — | 92337R101 |
| SANA BIOTECHNOLOGY INC | COM | $9.8M | 2,812,500 | — | 799566104 |
| MONTE ROSA THERAPEUTICS INC | COM | $9M | 372,474 | — | 61225M102 |
| LYELL IMMUNOPHARMA INC | COM NEW | $4.1M | 293,256 | — | 55083R203 |
| FIGMA INC | CLASS A COM STK | $3.9M | 215,582 | — | 316841105 |
| SPERO THERAPEUTICS INC | COM | $2M | 889,979 | — | 84833T103 |
| HYPERFINE INC | COM CL A | $1.2M | 898,720 | — | 44916K106 |
| AUTOLUS THERAPEUTICS PLC | SPON ADS | $1.1M | 698,262 | — | 05280R100 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-07